chr11-64300846-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039496.2(CATSPERZ):c.211G>A(p.Gly71Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000142 in 1,406,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001039496.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CATSPERZ | NM_001039496.2 | c.211G>A | p.Gly71Ser | missense_variant | 2/5 | ENST00000328404.8 | NP_001034585.1 | |
KCNK4-CATSPERZ | NR_133662.1 | n.2218G>A | non_coding_transcript_exon_variant | 8/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CATSPERZ | ENST00000328404.8 | c.211G>A | p.Gly71Ser | missense_variant | 2/5 | 1 | NM_001039496.2 | ENSP00000491717 | P2 | |
CATSPERZ | ENST00000539943.1 | c.85G>A | p.Gly29Ser | missense_variant | 1/4 | 2 | ENSP00000443917 | A2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000622 AC: 1AN: 160848Hom.: 0 AF XY: 0.0000115 AC XY: 1AN XY: 86736
GnomAD4 exome AF: 0.00000142 AC: 2AN: 1406972Hom.: 0 Cov.: 32 AF XY: 0.00000288 AC XY: 2AN XY: 695036
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.211G>A (p.G71S) alteration is located in exon 2 (coding exon 2) of the TEX40 gene. This alteration results from a G to A substitution at nucleotide position 211, causing the glycine (G) at amino acid position 71 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at